Zimmer Biomet Holdings, Inc. and its partner Canary Medical announced on 30 August that the US Food and Drug Administration cleared a de novo application for their Persona IQ implant, the first implantable smart device for total knee replacement that uses sensor-based technology to provide real-world post-surgical patient data for the care team and patients.
Zimmer Biomet, Canary Medical Win FDA De Novo For First Smart Knee Implant
Zimmer Biomet and Canary Medical’s FDA de novo clearance of the Persona IQ total knee implant intensifies Zimmer Biomet’s focus on data collection and analytics across continuum of care to improve outcomes and surgery methods, an analyst wrote.
